Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks

PLOS Neglected Tropical Diseases - Tập 9 Số 7 - Trang e0003846
Marc Lipsitch1,2, Christl A. Donnelly2, Christophe Fraser2, Isobel M. Blake2, Anne Cori2, Ilaria Dorigatti2, Neil M. Ferguson2, Tini Garske2, Harriet L. Mills2, Steven Riley2, Maria D. Van Kerkhove3, Miguel A. Hernán4
1Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America
2MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom
3MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom; Centre for Global Health, Institut Pasteur, Paris, France.
4Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America

Tóm tắt

Từ khóa


Tài liệu tham khảo

MD Van Kerkhove, 2010, Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling, PLoS Med, 7, e1000275, 10.1371/journal.pmed.1000275

2007

C Adebamowo, 2014, Randomised controlled trials for Ebola: practical and ethical issues, Lancet, 384, 1423, 10.1016/S0140-6736(14)61734-7

S Cauchemez, 2014, Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility, Lancet Infect Dis, 14, 50, 10.1016/S1473-3099(13)70304-9

M Lipsitch, 2011, Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1, Biosecur Bioterror, 9, 89

H Yu, 2013, Human infection with avian influenza A H7N9 virus: an assessment of clinical severity, Lancet, 382, 138, 10.1016/S0140-6736(13)61207-6

TT Wang, 2012, Seroevidence for H5N1 influenza infections in humans: meta-analysis, Science, 335, 1463, 10.1126/science.1218888

MD Van Kerkhove, 2012, Comment on "Seroevidence for H5N1 influenza infections in humans: meta-analysis", Science, 336, 1506, 10.1126/science.1221434

CA Donnelly, 2003, Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong, Lancet, 361, 1761, 10.1016/S0140-6736(03)13410-1

AM Presanis, 2009, The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis, PLoS Med, 6, e1000207, 10.1371/journal.pmed.1000207

AM Presanis, 2011, Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis, BMJ, 343, d5408, 10.1136/bmj.d5408

MG Baker, 2009, Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009, Euro Surveill, 14, 10.2807/ese.14.34.19319-en

KE Atkins, 2015, Under-reporting and case fatality estimates for emerging epidemics, BMJ, 350, h1115, 10.1136/bmj.h1115

AD Iuliano, 2009, Notes from the field: outbreak of 2009 pandemic influenza A (H1N1) virus at a large public university in Delaware, April-May 2009, Clin Infect Dis, 49, 1811, 10.1086/649555

C Fraser, 2009, Pandemic potential of a strain of influenza A (H1N1): early findings, Science, 324, 1557, 10.1126/science.1176062

M Lipsitch, 2009, Use of cumulative incidence of novel influenza A/H1N1 in foreign travelers to estimate lower bounds on cumulative incidence in Mexico, PLoS One, 4, e6895, 10.1371/journal.pone.0006895

C Pelat, 2014, Optimizing the precision of case fatality ratio estimates under the surveillance pyramid approach, Am J Epidemiol, 180, 1036, 10.1093/aje/kwu213

JT Wu, 2011, Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance data, PLoS Med, 8, e1001103, 10.1371/journal.pmed.1001103

JT Wu, 2010, The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong, Clin Infect Dis, 51, 1184, 10.1086/656740

S Cauchemez, 2013, Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart, Euro Surveill, 18, 10.2807/ese.18.24.20503-en

T Garske, 2009, Assessing the severity of the novel influenza A/H1N1 pandemic, BMJ, 339, b2840, 10.1136/bmj.b2840

2014, Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections, N Engl J Med, 371, 1481, 10.1056/NEJMoa1411100

AJ Kucharski, 2014, Case fatality rate for Ebola virus disease in west Africa, Lancet, 384, 1260, 10.1016/S0140-6736(14)61706-2

AC Ghani, 2005, Methods for estimating the case fatality ratio for a novel, emerging infectious disease, Am J Epidemiol, 162, 479, 10.1093/aje/kwi230

NP Jewell, 2007, Non-parametric estimation of the case fatality ratio with competing risks data: an application to Severe Acute Respiratory Syndrome (SARS), Stat Med, 26, 1982, 10.1002/sim.2691

M Lipsitch, 2009, Managing and reducing uncertainty in an emerging influenza pandemic, N Engl J Med, 361, 112, 10.1056/NEJMp0904380

BM Psaty, 1999, Assessment and control for confounding by indication in observational studies, J Am Geriatr Soc, 47, 749, 10.1111/j.1532-5415.1999.tb01603.x

SG Muthuri, 2014, Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data, The Lancet Respiratory Medicine, 2, 395, 10.1016/S2213-2600(14)70041-4

W Adisasmito, 2010, Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry, J Infect Dis, 202, 1154, 10.1086/656316

W Adisasmito, 2011, Strengthening observational evidence for antiviral effectiveness in influenza A (H5N1), J Infect Dis, 204, 810, 10.1093/infdis/jir398

PK Chan, 2012, Determinants of antiviral effectiveness in influenza virus A subtype H5N1, J Infect Dis, 206, 1359, 10.1093/infdis/jis509

MA Hernan, 2004, A structural approach to selection bias, Epidemiology, 15, 615, 10.1097/01.ede.0000135174.63482.43

S Greenland, 1996, Basic methods for sensitivity analysis of biases, Int J Epidemiol, 25, 1107, 10.1093/ije/25.6.1107

MD Van Kerkhove, 2011, Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis, PLoS Med, 8, e1001053, 10.1371/journal.pmed.1001053

S Balter, 2010, Pandemic (H1N1) 2009 surveillance for severe illness and response, New York, New York, USA, April-July 2009, Emerg Infect Dis, 16, 1259, 10.3201/eid1608.091847

CJ Gregory, 2012, Investigation of elevated case-fatality rate in poliomyelitis outbreak in Pointe Noire, Republic of Congo, 2010, Clin Infect Dis, 55, 1299, 10.1093/cid/cis715

K Mupapa, 1999, Ebola hemorrhagic fever and pregnancy, J Infect Dis, 179, S11, 10.1086/514289

A Majeed, 2001, Use of risk adjustment in setting budgets and measuring performance in primary care II: advantages, disadvantages, and practicalities, BMJ, 323, 607, 10.1136/bmj.323.7313.607

S Joffe, 2014, Evaluating novel therapies during the Ebola epidemic, JAMA, 312, 1299, 10.1001/jama.2014.12867

Bloom B (2014) Ebola: The Teaching and Learning Moment. Harvard International Review <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://hirharvardedu/archives/7500" xlink:type="simple">http://hirharvardedu/archives/7500</ext-link>.

S Cauchemez, 2009, Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States, N Engl J Med, 361, 2619, 10.1056/NEJMoa0905498